1 The effects of inhibition of peripheral aromatic L-amino acid decarboxylase during infusion of the relatively renally selective 5-hydroxytryptamine (5-HT) prodrug, y-L-glutamyl-5-hydroxy-L-tryptophan , were examined in eight healthy male subjects in a randomised, placebo-controlled, cross-over study. 2 Each subject received oral carbidopa (100 mg) or placebo followed, 1 h later, by a 60 min intravenous infusion of glu-5-HTP (16.6 jg kg-1 min-') or placebo.3 After administration of glu-5-HTP, cumulative urinary excretion of 5-HT was 430-fold greater than that after placebo, and was associated with a period of sodium retention. 4 Pretreatment with carbidopa substantially attenuated the increase in 5-HT excretion after glu-5-HTP and abolished its antinatriuretic effect. 5 These results are in keeping with the proposition that the antinatriuretic action of glu-5-HTP is dependent on its decarboxylation to 5-HT.
5-hydroxytryptamine sodium excretion ale y-L-glutamyl-5-hydroxy-L-tryptophan dosteroneThe first step in the biosynthesis of 5-hydroxytryptamine (5-HT; serotonin) involves the hydroxylation of the essential amino acid L-tryptophan to 5-hydroxytryptophan (5-HTP) by the enzyme tryptophan-5-hydroxylase. 5-HTP is decarboxylated by aromatic L-amino acid decarboxylase (LAAD) to 5-HT. The latter is degraded primarily by monoamine oxidase to produce 5-hydroxyindoleacetic acid (5-HIAA) which is the major catabolic and excretory product of 5-HT metabolism. All these enzymes are present in renal tissue, suggesting that the kidney might have the capacity to synthesise and degrade 5-HT locally [1,2]. The enzyme y-glutamyl transferase (yGT) is also present in high concentrations and the kidney is highly active in the uptake and metabolism of y-glutamyl derivatives of amino acids [3,4]. We previously demonstrated marked increases in urinary 5-HT excretion after infusion of the 5-HT prodrug, y-L-glutamyl-5-hydroxy-L-tryptophan (glu-5-HTP), in keeping with intrarenal synthesis of 5-HT following the conversion of glu-5-HTP to 5-HTP by yGT and its subsequent decarboxylation by renal LAAD to 5-HT [5,6]. Glu-5-HTP was relatively more selective for the kidney than 5-HTP. It reduced urinary sodium excretion without significant alterations in renal haemodynamics and this was due, presumably, to intrarenally generated 5-HT.The present study was designed to investigate whether carbidopa, a peripheral inhibitor of LAAD [7], blocks the formation of 5-HT from glu-5-HTP and interferes with the actions of glu-5-HTP in normal volunteers.
MethodsEight male volunteers, age range 18-39 years (mean 28 years) and weighing 59.9-80.9 kg (mean 69.0 kg),